Filing Analysis

Other SEC Filing Filed Mar 24, 2026
LOW

ReposiTrak, Inc. announced a quarterly cash dividend of $0.02 per share of common stock. The dividend is payable on May 15, 2026, to stockholders of record as of March 31, 2026.

Key Facts

  • Quarterly cash dividend declared: $0.02 per share.
  • Annualized dividend rate: $0.08 per share.
  • Record date for stockholders: March 31, 2026.
  • Payment date: On or about May 15, 2026.
  • The announcement was made via a press release on March 20, 2026.
Material Agreement Filed Mar 20, 2026
MEDIUM

ReposiTrak, Inc.'s subsidiary, PC Group, Inc., entered into a $4 million senior unsecured promissory note with SPAR Marketing Force, Inc. The agreement includes an initial $3 million loan, an 8% interest rate, and the issuance of 1 million shares of SPAR Group, Inc. common stock to ReposiTrak.

Red Flags

  • The loan is unsecured, increasing the risk of loss in the event of a default by the borrower.
  • The borrower is another micro-cap entity, and the loan represents a significant capital allocation away from ReposiTrak's core operations.
  • Complex price protection and anti-dilution clauses suggest potential volatility or risk regarding the value of the equity consideration.

Key Facts

  • The loan facility is for an aggregate principal amount of up to $4,000,000.
  • Initial advance of $3,000,000 was funded on March 16, 2026; an additional $1,000,000 is available after July 17, 2026.
  • The Note bears interest at 8.0% per annum, payable monthly, maturing on March 16, 2029.
  • ReposiTrak will receive 1,000,000 shares of SPAR Group, Inc. common stock at a deemed value of $0.80 per share.
  • The agreement includes anti-dilution and price protection provisions for the SPAR Group shares.
  • SPAR Group, Inc. provides an irrevocable and unconditional guaranty of the borrower's obligations.
Other SEC Filing Filed Mar 17, 2026
LOW

ReposiTrak, Inc. has appointed James Gillis to its Board of Directors and to the Audit and Compensation Committees, effective March 13, 2026. Mr. Gillis is an independent director who previously served on the company's board for seven years.

Key Facts

  • James Gillis appointed to the Board of Directors effective March 13, 2026.
  • Mr. Gillis will serve on the Audit and Compensation Committees.
  • He previously served on the ReposiTrak Board from February 2008 to March 2015.
  • Mr. Gillis is currently the CEO of Gillis & Associates, Inc., an M&A advisory firm.
  • The Board determined Mr. Gillis meets NYSE independence standards.
  • No related party transactions or specific arrangements were reported regarding his selection.
Regulation FD Disclosure Filed Feb 19, 2026
LOW

ReposiTrak, Inc. (TRAK) filed an 8-K on February 19, 2026 to disclose its fiscal quarter earnings results for the period ended December 31, 2025. The filing is a routine Regulation FD disclosure accompanying a press release and earnings call transcript, with no material agreements, red flags, or unusual items reported.

Red Flags

  • No financial figures disclosed in the 8-K itself — actual results are in the furnished exhibits (99.1 and 99.2) which were not included for analysis

Key Facts

  • Quarterly earnings results announced for fiscal quarter ended December 31, 2025
  • Press release issued and earnings call hosted on February 17, 2026
  • Filing signed by CFO John Merrill on February 19, 2026
  • Company is incorporated in Nevada, headquartered in Murray, Utah
  • Common stock (TRAK) listed on the New York Stock Exchange with $0.01 par value
  • Exhibits furnished (not filed): press release (99.1) and earnings call transcript (99.2)
  • Company is NOT an emerging growth company
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for TRAK

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial